
Sign up to save your podcasts
Or


In this episode, D. Ross Camidge, MD, PhD, and Joel W. Neal, MD, PhD, answer questions on investigational antibody-drug conjugates for advanced NSCLC
Presenters:
Ross Camidge, MD, PhD
Professor of Medicine/Oncology
University of Colorado Cancer Center
Aurora, Colorado
Joel W. Neal, MD, PhD
Associate Professor of Medicine
Division of Oncology
Department of Medicine
Stanford University
Attending Physician
Stanford Cancer Institute
Palo Alto, California
Content based on an online IME program supported by educational grants from Daiichi Sankyo, Inc .
Link to full program:
http://bit.ly/3twpIyl
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
By Clinical Care Options4.9
99 ratings
In this episode, D. Ross Camidge, MD, PhD, and Joel W. Neal, MD, PhD, answer questions on investigational antibody-drug conjugates for advanced NSCLC
Presenters:
Ross Camidge, MD, PhD
Professor of Medicine/Oncology
University of Colorado Cancer Center
Aurora, Colorado
Joel W. Neal, MD, PhD
Associate Professor of Medicine
Division of Oncology
Department of Medicine
Stanford University
Attending Physician
Stanford Cancer Institute
Palo Alto, California
Content based on an online IME program supported by educational grants from Daiichi Sankyo, Inc .
Link to full program:
http://bit.ly/3twpIyl
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

4,354 Listeners

318 Listeners

497 Listeners

765 Listeners

115 Listeners

57 Listeners

2,442 Listeners

3,339 Listeners

9,517 Listeners

44 Listeners

1,032 Listeners

22 Listeners

85 Listeners

57 Listeners

189 Listeners